Injectable codeine is readily available for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this may result in nonimmune mast-mobile degranulation and resulting anaphylactoid response. Codeine suppositories are promoted in some nations. In Eire, new restrictions came into impact on 1 August 2010[90] concerning codeine, due to problems https://codeingil.com/